nDatalyze Corp. (CSE:NDAT)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Jun 30, 2025, 11:34 AM EDT
nDatalyze Revenue
nDatalyze had revenue of 887.00 CAD in the twelve months ending May 31, 2025, down -98.94% year-over-year. In the fiscal year ending February 28, 2025, nDatalyze had annual revenue of 1.71K, down -98.22%.
Revenue (ttm)
887.00
Revenue Growth
-98.94%
P/S Ratio
698.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
619.91K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 1.71K | -94.63K | -98.22% |
| Feb 29, 2024 | 96.34K | -74.87K | -43.73% |
| Feb 28, 2023 | 171.22K | -253.71K | -59.71% |
| Feb 28, 2022 | 424.93K | -237.84K | -35.89% |
| Feb 28, 2021 | 662.77K | 131.60K | 24.78% |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.57B |
| Curaleaf Holdings | 1.75B |
| Sienna Senior Living | 896.45M |
| dentalcorp Holdings | 1.62B |
| Trulieve Cannabis | 1.62B |
| WELL Health Technologies | 990.34M |
| Cronos Group | 177.69M |
| Extendicare | 1.51B |
nDatalyze News
- 4 months ago - nDatalyze cancels reverse takeover of ThriveTech - Seeking Alpha